Monday, June 4, 2018
- 6:00pm-7:00pm
-
The Novel Polymer Pro-Drug APP-103 Reduces I/R Injury and Improves Graft Function in a Pre-Clinical Renal Transplant Model
Poster Session C: Antigen Presentation • Hall 4EF
- 6:00pm-7:00pm
-
The Outcomes of Candidates Underwent Liver Transplantaion with Portopulmonary Hypertension: A Meta-Analysis
Poster Session C: Liver: Recipient Selection • Hall 4EF
- 6:00pm-7:00pm
-
The Ratio of CTLA4 to Perforin and Granzyme B as a Potential Biomarker of Tolerance in Chimeric Renal Transplant Patients
- 6:00pm-7:00pm
-
Time within Therapeutic Range: A Comparison of Three Tacrolimus Formulations in Renal Transplant Recipients
- 6:00pm-7:00pm
-
Time-Effect of Donor and Recipient Characteristics on Graft Survival after Kidney Transplantation
- 6:00pm-7:00pm
-
Timing of Treatment for Chronic Hepatitis C Infection in Patients with End-Stage Renal Disease Awaiting Transplantation